Latest Book

Preparative Chromatography for Separation of Proteins and Peptides, Ed. By A. Staby, S. Ahuja, and A. S. Rathore, Wiley Interscience, 2017.



BOOKS

• Preparative Chromatography for Separation of Proteins and Peptides, Ed. By A. Staby, S. Ahuja, and A. S. Rathore, Wiley Interscience, 2017.

• Process Validation in Manufacturing of Biopharmaceuticals, Edition 3, Ed. By A. S. Rathore and G. Sofer, Taylor and Francis, 2012.

• Quality by Design for Biopharmaceuticals: Perspectives and Case Studies, Ed. by A. S. Rathore and R. Mhatre, Wiley Interscience, 2009, New Jersey.

• Elements of Biopharmaceutical Production Series, Ed. By A. S. Rathore, Advanstar Communications, New York, 2007.

• Process Validation in Manufacturing of Biopharmaceuticals, Ed. By A. S. Rathore and G. Sofer, CRC Press, 2005.

• Electrokinetic phenomena: Principles and Applications in Analytical Chemistry and Microchip Technology, Ed. by A. S. Rathore and A. Guttman, Marcel Dekker, 2003.

• Scale-up and Optimization in Preparative Chromatography, Ed. by A. S. Rathore and A. Velayudhan, Marcel Dekker, 2002.

FILED PATENT DISCLOSURES

• “Fingerprinting Biotherapeutics with FTIR Spectroscopy'', Indian Patent Application 201911032987 filed on 30th August 2019 at the Indian Patent Office.

• “Bioprocess Performance Enhancing Strains Of Escherichia Coli”, Indian Patent Application No. 201911033511 dated August 20, 2019

• “A system for monitoring and control of chromatography”, application IN100482 filed on 28th March 2019 at the Indian Patent Office, PCT/IN2020/050264 filed on March 20, 2020, Publication number WO 2020/053875 on March 19, 2020.

• “Process for producing recombinant peptides”, application PD028671IN filed on 14th September 2018 at the Indian Patent Office. PD028671PCT filed on 24th June 2019.

• “Polypeptide sequence and composition thereof”, Disclosure 201711030494 filed on 28 September 2017 the Indian Patent Office.

• “A formulation for stabilizing biotherapeutics”, PD022345IN filed on 9th December 2016, PD022345PCT filed on 8th June 2017.

• “Method for monitoring of foulants present on chromatographic resins using fluorescence probe”, Patent Application No. 201611015421, filed June 7, 2016 at the Indian Patent Office, Date of Grant: 23 January 2020, Patent number: 330088. PCT/IN2017/050035 filed 12th July 2018. US Patent App. 16/069,745.

• “A low cost process for production of snake antivenom peptide”, application PD015790IN, filed 20th March 2015 at the Indian Patent Office.

• “An innovative coiled flow inverted reactor for continuous refolding of denatured recombinant proteins”, application 185/DEL/2015 filed 21st January 2015 at the Indian Patent Office, PCT/IN2016/000022 filed 20th January 2016.

• “A process for purification of recombinant granulocyte colony stimulating factor”, Application 1880/DEL/2012, filed 19th June 2012 at the Indian Patent Office. PCT application 13/921891 filed 19th June 2013 at US Patent Office, Patent number 9422354.

• “Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof”, application #20040048315, filed 26th August 2003, granted 3rd April 2012, Patent number 8148331.

• “Methods for decreasing aggregate levels of pegylated growth hormone antagonists”, filed Sep 22nd 2003, granted 30 December 2008, Patent number 7470779.

TECHNOLOGIES DEVELOPED

• An innovative coiled flow inverted reactor for continuous refolding of denatured recombinant proteins (patent application filed for US and for India)

• Creation of a novel aqueous two phase extraction process for purification of biotech therapeutics (patent application filed for US and for India)

• Creation of a novel single step process for purification of biotech therapeutics (patent application filed for US and for India)

• CFD modeling of a helical coil heat exchanger to aid in scaleup from lab to manufacturing scale for Ranbaxy laboratories

• Creation of a high throughput process development (HTPD) protocol for development of biotech processes for GE Healthcare 

• Proposed a novel approach for using multivariate data analysis (MVDA) for evaluating comparability of biotech processes and products for Dr Reddy Laboratories 

• Developed a process analytical technology (PAT) based control scheme for a process chromatography column for Biocon Ltd. 

• Creation of manufacturing process for Granulocyte Colony Stimulating Factor (GCSF), a biotech therapeutic - in negotiation with Indian biotech companies for licensing
  

PUBLICATIONS (Complete List)

1. Tanu Bhardwaj, Priyanka Dalal, A. S. Rathore, and S. K. Jha, An aptamer based microfluidic chip for impedimetric detection of Ranibizumab in a bioreactor, Sensors and Actuators B: Chemical, 312(2020) 127941.
2. V Hebbi, S Roy, A. S. Rathore, and A. Shukla, Modeling and prediction of excipient and pH drifts during ultrafiltration/diafiltration of monoclonal antibody biotherapeutic for high concentration formulations, Separation and Purification Technology, 238 (2020) 116392.
3. R Kumar, RL Shah, and A. S. Rathore, Harnessing the power of electrophoresis and chromatography: Offline coupling of reverse phase liquid chromatography-capillary zone electrophoresis-tandem mass spectrometry for peptide mapping for monoclonal antibodies, Journal of Chromatography A, (2020) in print.
4. A Mishra, RS Patil, S Singh, and A. S. Rathore, Mechanistic explanation of structural and functional changes induced by methionine mutation in G-CSF protein, Current Research in Biotechnology, (2020) in print.
5. S Sreenivasan, D Kumar, H Malani, and A. S. Rathore, Does interaction of monoclonal antibody charge variants with VEGF-A and ELISA reagents affect its quantification?, Analytical Biochemistry, (2020) in print.
6. A. S. Rathore, and A. Bhargava, Biosimilars in Developed Economies: Overview, Status, and Regulatory Considerations, Regulatory Toxicology and Pharmacology, (2020) in print.
7. S. Joshi and A. S. Rathore, Assessment of Structural and Functional Comparability of Biosimilar Products: Trastuzumab as a Case Study, Biodrugs, (2020) in print.
8. R Bansal, P Srivastava, A. S. Rathore, and P Chokshi, Population balance modelling of aggregation of monoclonal antibody based therapeutic proteins, Chemical Engineering Science, 216 (2020) 115479.
9. G Thakur, V Hebbi, and A. S. Rathore, An NIR‐based PAT approach for real‐time control of loading in Protein A chromatography in continuous manufacturing of monoclonal antibodies, Biotechnology Bioengineering, 117 (2020) 673–686.
10. V. Hebbi, D. Kumar, and A. S. Rathore, Process intensification in peptide manufacturing: Recombinant lethal toxin neutralizing factor (rLTNF) as a case study, Process Biochemistry, 90 (2020) 193-203.
11. SK Singh, G Goel and A. S. Rathore, A novel approach for protein identification from complex cell proteome using modified peptide mass fingerprinting algorithm, Electrophoresis, 40 (2019) 3062-3073.
12. M Pathak, K Lintern, TF Johnson, AM Nair, S Mukherji, DG Bracewell and A. S. Rathore, Analytical tools for monitoring changes in physical and chemical properties of chromatography resin upon reuse, Electrophoresis, 40 (2019) 3074-3083.
13. R Bansal, S Gupta, and A. S. Rathore, Analytical platform for monitoring aggregation of monoclonal antibody therapeutics, Pharmaceutical Research, 36 (2019) 152.
14. SK Singh, A Mishra, D Yadav, N Budholiya, and A. S. Rathore, Understanding the mechanism of copurification of “difficult to remove” host cell proteins in rituximab biosimilar products, Biotechnology Progress, (2019) e2936.
15. N. Budholiya, S. Roy, and A. S. Rathore, Neural network–based fingerprinting of monoclonal antibody aggregation using biolayer interferometry, Analytical and Bioanalytical Chemistry, (2019) 1-10.
16. A. S. Rathore, R. Kumar, I. S. Krull, Practical Considerations of Capillary Electrophoresis Mass Spectrophotometry for Analysis of Biotherapeutics, LC GC North America, 37 (2019), 386-391.
17. S. Ghosh, S. Alam, A. S. Rathore, S. K. Khare. Stability of Therapeutic Enzymes: Challenges and Recent Advances, in Therapeutic Enzymes: Function and Clinical Implications, Ed. N. Labrou, Springer, Singapore, 2019, 131-150.
18. V. Hebbi, S Chattopadhyay, and A. S. Rathore, High performance liquid chromatography (HPLC) based direct and simultaneous estimation of excipients in biopharmaceutical products, Journal of Chromatography B, 1117 (2019) 118-126.
19. D Kumar, J Batra, C Komives, A. S. Rathore, QbD Based Media Development for the Production of Fab Fragments in E. coli, Bioengineering, 6 (2019) 29.
20. V. Halan, S. Maity, R. Bhambure, and A. S. Rathore, Multimodal Chromatography for Purification of Therapeutics- A Review, Current Peptide and Protein Science 20 (2019)  4-13.
21. L. K. Shekhawat, A. S. Rathore, An overview of mechanistic modeling of liquid chromatography, Preparative Biochemistry and Biotechnology, 49 (2019) 623-638.
22. A. S. Rathore, AG Vulto, JG Stevenson, VP Shah, Challenges with Successful Commercialization of Biosimilars, BioPharm International, 32 (2019), 22.
23. V. Hebbi, G. Thakur, and A. S. Rathore, Process analytical technology implementation for protein refolding: GCSF as a case study, Biotechnology Bioengineering, 116 (2019) 1039-1052.
24. N. Nupur, N. Chhabra, R. Dash, and A. S. Rathore, Usability of NISTmAb reference material for biosimilar analytical development, Analytical and Bioanalytical Chemistry, 411 (2019) 2867–2883.
25. A. S. Rathore, R. Dash, Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars, BioPharm International, 32 (2019), 34-49.
26. L. K. Shekhawat, A. S. Rathore, Mechanistic modeling based process analytical technology implementation for pooling in hydrophobic interaction chromatography, Biotechnology Progress, 35 (2019).
27. A. S. Rathore, F. Shereef, The influence of domestic manufacturing capabilities on biologic pricing in emerging economies, Nature Biotechnology, 37(2019), 498-501.
28. A. S. Rathore, F. Shereef, Shadow pricing and the art of profiteering from outdated therapies, Nature Biotechnology, 37(2019), 217–220.
29. Priyanka, S. Roy, VR Chopda, J. Gomes, A. S. Rathore, Comparison and implementation of different control strategies for improving production of rHSA using Pichia pastoris,  Journal of Biotechnology, 290 (2019) 33-43.
30. A. S. Rathore, R. Bansal, Modeling the Degradation of mAb Therapeutics, BioPharm International, 32 (2019), 41.
31. J. Auclair, A. S. Rathore, I. S. Krull, Methods and Purposes for Determining Higher Order Structures of Biopharmaceuticals, LC GC North America, 37 (2019), 34-43.
32. L. K. Shekhawat, A. Godara, V. Kumar, and A. S. Rathore, Design of experiments applications in bioprocessing: Chromatography process development using split design of experiments, Biotechnology Progress, 35 (2019) e2730.
33. J. Gomes, V. Chopda, A. S. Rathore, Monitoring and control of bioreactor: basic concepts and recent advances, in Bioprocessing Technology for Production of Biopharmaceuticals and Bioproducts, John Wiley & Sons, Inc., 2018, 201-237.
34. A. S. Rathore, N. Kateja, D. Kumar, Process integration and control in continuous bioprocessing, Current Opinion in Chemical Engineering, 22 (2018) 18-25.
35. A. S. Rathore, I. S. Krull, S. Joshi, Analytical Characterization of Biotherapeutic Products Part II: The Analytical Toolbox, LC GC North America, 36 (2018), 814.
36. L. K. Shekhawat, M. Pathak, J. Sarkar, and A. S. Rathore, Process development in the Quality by Design paradigm: Modeling of Protein A chromatography resin fouling, J. Chromatogr. A, 1570 (2018) 56-66.
37. S. Madan, C. Nehate, T. K. Burman, A. S. Rathore, V. Koul, Design, Preparation and Evaluation of Liposomal Gel Formulations for Treatment of Acne: In vitro and In vivo Studies, Drug Development and Industrial Pharmacy, 45 (2019) 395-404.
38. N. Kateja, D. Kumar, S. Sethi, and A. S. Rathore, Non-protein A purification platform for continuous processing of monoclonal antibody therapeutics, Journal of Chromatography A 1579 (2018) 60–72.
39. A Tiwari, N Kateja, S Chanana, A. S. Rathore, Use of HPLC as an enabler of process analytical technology in process chromatography, Analytical Chemistry, 90 (2018) 7824-7829.
40. M Garg, M Roy, P Chokshi, A. S. Rathore, Process development in the QbD paradigm: mechanistic modeling of antisolvent crystallization for production of pharmaceuticals, Crystal Growth & Design, 18 (2018), 3352-3359
41. A. S. Rathore, A. Chauhan, Transcriptomics and the Production of Recombinant Therapeutics, BioPharm International, (2018), in print.
42. S Ravuluri, R Bansal, N Chhabra, A. S. Rathore, Kinetics and Characterization of Non-enzymatic Fragmentation of Monoclonal Antibody, Pharmaceutical Research, 35 (2018), 142.
43. A. S. Rathore, D. Kumar, N. Kateja, Recent developments in chromatographic purification of biopharmaceuticals, Biotechnology Letters, 2018, in print.
44. M. C.  Nweke, A. S. Rathore, D. G. Bracewell, Lifetime and Aging of Chromatography Resins during Biopharmaceutical Manufacture, Trends in Biotechnology, 36 (2018), 992-995.
45. VS Joshi, V Kumar, A. S. Rathore, Enhanced product understanding in the QbD paradigm: linkage between charge heterogeneity and stability of monoclonal antibody therapeutic products, Journal of Chemical Technology & Biotechnology, 8 (2018), 2102-2110.
46. A. S. Rathore, DK Yadav, SS Pandey, SK Singh, D Kumar, Preclinical Evaluation of Product Related Impurities and Variants, BioPharm International, 31 (2018), 26-32
47. A. S. Rathore, D. Kumar, N. Kateja, Role of raw materials in biopharmaceutical manufacturing: risk analysis and fingerprinting, Current Opinion in Biotechnology, 53 (2018) 99-105.
48. J.R. Auclair, A. S. Rathore, I Krull, Charge-Variant Profiling of Biopharmaceuticals, LC GC North America, 36 (2018), 26-36
49. J Gomes, J Batra, VR Chopda, P Kathiresan, A. S. Rathore, Monitoring and Control of Bioethanol Production From Lignocellulosic Biomass, in Waste Biorefinery: Potential and Perspectives, Eds. T Bhaskar, A Pandey, S. V. Mohan, D-J Lee, S K Khanal, Elsevier, Amsterdam, The Netherlands, 2018, 727-749
50. L. K. Shekhawat, J. Sarkar, R. Gupta, S. Hadpe, and A. S. Rathore, Application of CFD in Bioprocessing: Separation of mammalian cells using disc stack centrifuge during production of biotherapeutics, Journal of Biotechnology, 267 (2018) 1-11.
51. A. S. Rathore, Approval of Ogivri, PDA Journal of Pharmaceutical Science and Technology, 72 (2018) 1-1.
52. M. Pathak, K. Lintern, D. G. Bracewell , and A. S. Rathore, Protein A Chromatography Resin Lifetime - Impact of Feed Composition, Biotechnology Progress, 34 (2018) 412-419.
53. A.S. Rathore, D. Kumar, J. Batra, I. Krull, Biolayer Interferometry as an Alternative to HPLC for Measuring Product Concentration in Fermentation Broth,  LC GC North America, 35 (2017), 870-877.
54. V. Hebbi, P. Kathiresan, D. Kumar, C. Komives, and A. S. Rathore, Process for production and purification of Lethal Toxin Neutralizing Factor (LTNF) from E. coli and its economic analysis, Journal of Chemical Technology and Biotechnology, 93 (2018) 959-967.
55. N. Nupur, N. Chhabra, R. Dash, and A. S. Rathore, Assessment of Structural and Functional Similarity of Biosimilar Products: Rituximab as a case study, mAbs, 10 (2018) 143-158.
56. R. Bansal, S. Dhawan, S. Chatterjee, G. Maurya, V. Haridas, A. S. Rathore, Peptide dendrons as thermal stability amplifiers for IgG1 monoclonal antibody biotherapeutics, Bioconjugate Chemistry (2017) DOI: 10.1021/acs.bioconjchem.7b00389.
57. Sumit K. Singh, D. Kumar, and A. S. Rathore, Determination of Critical Quality Attributes for a Biotherapeutic in the QbD Paradigm: GCSF as a Case Study, The AAPS Journal, 19 (2017) 1826-1841
58. N. Kateja, D. Kumar, A. Godara, V. Kumar, and A. S. Rathore, Integrated Chromatographic Platform for Simultaneous Separation of Charge Variants and Aggregates from Monoclonal Antibody Therapeutic Products, Biotechnology Journal (2017) DOI: 10.1002/biot.201700133.
59. A. S. Rathore, N. Kateja, H. Agarwal, Continuous Downstream Processing for Production of Biotech Therapeutics, in Continuous Downstream Processing, Taylor and Francis, 2017, 261-287.
60. P. Misra, A. Sinha, F. Q. Mir, A. S. Rathore, and A. Shukla A three plus three parameters mechanistic model for viral filtration, Biotechnology Progress (2017) DOI:10.1002/btpr.2523.
61. M. Pathak and A. S. Rathore, Implementation of a Fluorescence Based Process Analytical Technology Control of Fouling of Protein A Chromatography Resin, Journal of Chemical Technology and Biotechnology. 92 (2017) 2799–2807.
62. N. Kateja, H. Agarwal, V. Hebbi, and A. S. Rathore, A coiled flow inversion reactor enables continuous processing, BioPharm International (2016) DOI 10.1002/biot.201600271.
63. V. Kumar and A. S. Rathore, Mechanistic Modeling of Ion-Exchange Process Chromatography of Charge Variants of Monoclonal Antibody Products: Application for PAT Implementation, Biotechnology Journal (2017) DOI:10.1002/biot.201700286.
64. V. S. Joshi, V. Kumar and A. S. Rathore, Optimization of ion exchange sigmoidal gradients using hybrid models: Implementation of quality by design in analytical method development, Journal of Chromatography A 1491 (2017) 145-152.
65. L. K. Shekhawat, M. Chandak and A. S. Rathore, Mechanistic modeling of hydrophobic interaction chromatography for purification of monoclonal antibody therapeutics: Process optimization in the quality by design paradigm, Journal of Chemical Technology and Biotechnology. 92 (2017) 2527–2537.
66. N. Kateja, H. Agarwal, V. Hebbi, and A. S. Rathore, Integrated continuous processing of proteins expressed as inclusion bodies: GCSF as a case study, Biotechnology Progress 33 (2017) 998-1009.
67. S. R. Hadpe, A. K. Sharma, V. V. Mohite and A. S. Rathore, ATF for cell culture harvest clarification: Mechanistic modelling and comparison with TFF, Journal of Chemical Technology and Biotechnology. 92 (2017) 732-740.
68. C. Komives, E. Sanchez, A. S. Rathore, B. White, M. Suntravat, M. Balderrama, A. Cifelli, V. Joshi, Opossum peptide that can neutralize rattlesnake venom is expressed in Escherichia coli, Biotechnology Progress 33 (2017) 81-86.
69. R. Singh, R. Jindal, A. S. Rathore, and G. Goel, Equilibrium Ensembles for Insulin Folding from Bias-Exchange Metadynamicsts, Biophysical Journal 112 (2017) 1571-1585.
70. J. Batra and A. S. Rathore, Glycosylation of Monoclonal Antibody Products: Current Status and Future Prospects, Biotechnology Progress 32 (2016) 1091-1102.
71. H. Agarwal, S. R. Hadpe, S. J. Alva and A. S. Rathore, Artificial neural network (ANN) based prediction of depth filter loading capacity for filter sizing, Biotechnology Progress 32 (2016) 1436-1443.
72. M. Pathak, K. Lintern, V. Hopda, D. G. Bracewell, and A. S. Rathore, Fluorescence based real time monitoring of fouling in process chromatography, Scientific Reports. 7 (2017) doi:10.1038/srep45640.
73. K. Lintern, M. Pathak, C. M. Smales, K. Howland, A. S. Rathore, and D. G. Bracewell, Residual on column host cell protein analysis during lifetime studies of protein A chromatography, J. Chromatogr. A 1461 (2016) 70-77.
74. N. Kateja, H. Agarwal, A. Saraswat, M. Bhat, and A. S. Rathore, Continuous precipitation of process related impurities from clarified cell culture supernatant using a novel coiled flow inversion reactor (CFIR), BiotechnologyJournal 11(2016) 1320-1331.
75. Sumit K. Singh, V. Hebbi, A. S. Rathore, and I.S. Krull, Practical Considerations of Capillary Electrophoresis-Mass Spectrophotometry for Analysis of Biotherapeutics, LC GC North America, September, 2016.
76. S. K. Singh, G. Narula, and A. S. Rathore, Should charge variants of monoclonal antibody therapeutics be considered critical quality attributes?, Electrophoresis, 37 (2016) 2338-2346.
77. M. Pathak and A. S. Rathore, Mechanistic understanding of fouling of Protein A chromatography resin, Journal of Chromatography A 1459 (2016) 78-88.
78. A. S. Rathore, N. Kateja, H. Agarwal, A. K. Sharma, Continuous Processing for Production of Biopharmaceuticals, BioPharm International 29 (2016) 14-19.
79. A. S. Rathore and G. Kapoor, Implementation of Quality by Design for Processing of Food Products and Biotherapeutics, Food and Bioproducts Processing 99 (2016) 231-243.
80. V. R. Chopda, M. Pathak, J. Batra, J. Gomes, and A. S. Rathore, Enabler for Process Analytical Technology Implementation in Pichia pastoris Fermentation: Fluorescence Based Soft Sensors for Rapid Quantitation of Product Titer, Engineering in Life Sciences 17 (2016), 448-457.
81. J. Batra and A. S. Rathore, Antibody Production in Microbial Hosts, BioPharm International 2(2016) 18-23.
82. P. Kathiresan, J. Kumar, V. Chopda, S. Jain, M. Banerjee, A. S. Rathore, J. Gomes, An Input-Output Linearizing Controller for Producing Angiogenin from E. coli, in Microbes in the Spotlight: Recent Progress in the Understanding of Beneficial and Harmful Microorganisms, BrownWalker Press, 2016, 379-384.
83. A. S. Rathore, V. R. Chopda, J. Gomes, Knowledge Management in a Waste based Biorefinery in the QbD Paradigm, Bioresource Technology 215 (2016) 63-75.
84. A. S. Rathore, S. K. Singh, Production of Protein Therapeutics in the Quality by Design (QbD) Paradigm, in Protein Therapeutics, Topics in Medicinal Chemistry, Eds. Prof. Zuben Sauna and Prof. Chava Kimchi-Sarfaty, Springer, 2016, 1-27.
85. A. S. Rathore, M. Pathak, and A. Godara, Process Development in the QbD Paradigm: Role of Process Integration in Process Optimization for Production of Biotherapeutics, Biotechnology Progress, 32 (2016) 355-362.
86. V. R. Chopda, J. Gomes, and A. S. Rathore, Bridging the gap between PAT concepts and implementation: An integrated software platform for fermentation, Biotechnology Journal 11 (2016) 164-171.
87. N. Nupur, S. K. Singh, G. Narula, and A. S. Rathore, Assessing analytical comparability of biosimilars: GCSF as a case study, J. Chromatogr. B, 1032 (2016) 165-171.
88. M. Pathak, S. Dixit, S. Muthukumar, and A. S. Rathore, In-vitro refolding of recombinant human granulocyte colony stimulating factor: Mechanistic understanding and its application towards process design, Journal of Pharmaceutical and Biomedical Analysis 126 (2016) 124-131.
89. V. Kumar, S. Leweke, E. von Lieres, and A. S. Rathore, Mechanistic Modeling of Ion-Exchange Process Chromatography of Charge Variants of Monoclonal Antibody Products, J. Chromatogr. A 1426 (2015) 140-153.
90. A. S. Rathore, M. Pathak, R. Jain, and G.P.S. Jadaun, Monitoring Quality of Biotherapeutic Products Using Multivariate Data Analysis, AAPS Journal 18 (2016) 793-800.
91. A. Singla, R. Bansal, V. Joshi, and A. S. Rathore, Aggregation Kinetics for IgG1 Based Monoclonal Antibody Therapeutics, AAPS Journal 18 (2016) 689-702.
92. A. S. Rathore, Quality by Design (QbD) based Process Development for Purification of a Biotherapeutic, Trends in Biotechnology 34 (2016) 358-370.
93. S. Muthukumar, T. Muralikrishnan, R. Mendhe, and A. S. Rathore, Economic benefits of membrane chromatography versus packed bed column purification of therapeutic proteins expressed in microbial and mammalian hosts, Journal of Chemical Technology and Biotechnology, 92 (2017) 59-68.
94. J. Sarkar, L. K. Shekhawat, V. Loomba, and A. S. Rathore, CFD of Mixing of Multiphase Flow in a Bioreactor using Population Balance Model, Biotechnology Progress, 32 (2016) 613-628.
95. O. F. Garcia-Aponte, A. Golabgir, B. M. Valejo-Diaz, A. S. Rathore, and C. Herwig, Clarifying the Role of Knowledge Management in QbD: A Review, Pharmaceutical Research, (2016) 1-14.
96. A. K. Sharma, H. Agarwal, M. Pathak, K. D. P. Nigam, and A. S. Rathore, Continuous Refolding of a Biotech Therapeutic in a Novel Coiled Flow Inverter Reactor, Chemical Engineering Science, 140 (2016) 153-160.
97. G. Narula, V. Hebbi, S. K. Singh, A. S. Rathore, and I.S. Krull, Glycosylation in mAb Therapeutic Products: Analytical Characterization and Impact of Process, LC GC North America, January, 2016.
98. A. S. Rathore, S. K. Singh, N. Nupur, G. Narula, Role of Proteomics in Characterization of Biological Products, in Biomarker Discovery in the Developing World: Dissecting the Pipeline for Meeting the Challenges, Advances in Experimental Medicine and Biology Series, Ed. S. Srivastava, Springer India, 2016, 83-97.
99. A. S. Rathore, L. Kanwar, V. Loomba, Computational Fluid Dynamics for Bioreactor Design, in Bioreactors: Design, Operation and Novel Applications, Ed. C.-F. Mandenius, Wiley VCH, Weinheim, Germany, 2016, pages 295-322.
100. L. K. Shekhawat, A. P. Manvar, and A. S. Rathore, Enablers for QbD Implementation: Mechanistic modeling for ion-exchange membrane chromatography, J. Mem. Sci. 500 (2016) 86-98.
101. V. R. Chopda, J. Gomes, and A. S. Rathore, Maximizing biomass concentration in baker’s yeast process by using a decoupled geometric controller for substrate and dissolved oxygen, Bioresource Technology 196 (2015) 160-168.
102. I.S. Krull and A. S. Rathore, Challenges in the Determination of Protein Aggregates, LC GC North America, Part 1: January, 2015, Part 2: July, 2015.
103. A. S. Rathore, M. Pathak, G. Ma, and D. G. Bracewell, Reuse of Protein A Resin: Fouling and Economics, BioPharm International (2015) March.
104. S. Muthukumar and A. S. Rathore, Use of Polymeric Membranes for Purification of an E. coli Expressed Biotherapeutic Protein, PreparativeBiochemistry andBiotechnology 46 (2016) 183-191.
105. A. S. Rathore, H. Agarwal, A. K. Sharma, M. Pathak, and S. Muthukumar, Continuous Processing for Production of Biopharmaceuticals, PreparativeBiochemistry andBiotechnology,  45 (2015) 836-849.
106. A. S. Rathore, M. Pathak, S. K. Singh, E. K. Read, and K. Brorson, Fermentanomics: Relating Quality Attributes of a Monoclonal Antibody to Cell Culture Process Variables and Raw Materials using Multivariate Data Analysis, Biotechnology Progress, 31 (2015) 1586-1599.
107. V. Joshi, V. Kumar, and A. S. Rathore, Role of Organic Modifier and Gradient Shape in RP-HPLC Separation: Analysis of GCSF Variants, J. Chromatogr. Sci. 53 (2015) 417-423.
108. V. Joshi, V. Kumar, and A. S. Rathore, Rapid analysis of charge variants of monoclonal antibodies using non-linear salt gradient in cation-exchange high performance liquid chromatography, Journal of Chromatography A, 1406 (2015) 175-185.
109. C. Herwig, O. F. Garcia-Aponte, A. Golabgir, and A. S. Rathore, Knowledge Management in the QbD Paradigm: Manufacturing of Biotech Therapeutics, Trends in Biotechnology, 33 (2015) 381-387.
110. A. S. Rathore, S. K. Singh, Use of Multivariate Data Analysis in Bioprocessing, BioPharm International 28 (2015) 26-31.
111. A. S. Rathore, Biosimilars in India. Journal of Proteomics 127 (2015) 71-72. 
112. R. Seth, P. Singh, K. Puri, A. Arora, and A. S. Rathore, Morbidity profile and outcome of hyperleukocytosis in childhood acute leukemia : experience from a tertiary center, Int. J. Hematology Research 2 (2015) 90-94.
113. J. Gomes, V. R. Chopda, and A. S. Rathore, Integrating Systems Analysis and Control for Implementing Process Analytical Technology in Bioprocess Development, J Chem Technol Biotechnol 90 (2015) 583-589.
114. V. Joshi, A. S. Rathore, and I. Krull, Sigmoidal Gradients in the HPLC-Based Analysis of
     Biotherapeutic Products, LC GC North America, August, 2015.
115. R. Mendhe, T. Muralikrishnan, N. Patil, and A. S. Rathore, Comparison of PAT based Approaches for Making Real-time Pooling Decisions for Process Chromatography- Use of Feed Forward Control, J Chem Technol Biotechnol 90 (2015) 341-348.
116. A. S. Rathore and G. Kapoor, Application of Process Analytical Technology for Downstream Purification of Biotherapeutics, J Chem Technol Biotechnol 90 (2015) 228-236.
117. S. Muthukumar, A. Shukla, and A. S. Rathore, Modeling of Filtration Processes- Microfiltration and Depth Filtration for Harvest of a Therapeutic Protein Expressed in Pichia pastoris at Constant Pressure, Bioengineering, 1 (2014) 260-277.
118. A. S. Rathore, R. Jain, M. Kalaivani, G. Narula and G. N. Singh, Setting Standards for Biotech Therapeutics in India, BioPharm International, October, 2014, 2-7.
119. A. S. Rathore, V. Joshi, V. Kumar and I. Krull, Role of elution gradient shape in separation of protein therapeutics, LC GC North America, September, 2014.
120. V. Joshi, T. Shivach, N. Yadav, and A. S. Rathore, Circular Dichoism Spectroscopy as a Tool for Measurement and Assessment of Aggregation in Monoclonal Antibody Therapeutics, Anal. Chem. 86 (2014) 11606-11613.
121. V. Kumar and A. S. Rathore, Two-Stage Chromatographic Separation of Aggregates for Monoclonal Antibody Therapeutics, J. Chromatogr. A 1368 (2014) 155-162.
122. A. S. Rathore, Quality by Design for Manufacturing of Biotech Therapeutics, Pharma Times,  46 (2014) 57-59.
123. A. Heckendorf, M. Gilar, I.S. Krull, and A. S. Rathore, HILIC and Its Applications for Biotechnology, LC GC North America, Part 1: December 2013, Part 2: January, 2014.
124. A. S. Rathore, QbD/ PAT for Bioprocessing: Moving from Theory to Implementation, Current Opinion in Chemical Engineering, 6 (2014) 1-8.
125. A. S. Rathore, S. Mittal, M. Pathak and V. Mahalingam, Chemometrics Application in Biotech Processes: Assessing Comparability across Processes and Scales, J Chem Technol Biotechnol 89 (2014) 1311-1316.
126. A. S. Rathore, A. Weiskopf and A.J. Reason, Defining Critical Quality Attributes for Monoclonal Antibody Therapeutic Products, BioPharm International, July, 2014, 34-43.
127. V. Joshi, T. Shivach, V. Kumar, N. Yadav, and A. S. Rathore, Avoiding Antibody Aggregation During Processing: Establishing Hold Times, Biotechnol. J. 9 (2014) 1195-1205.
128. M. Pathak, D. Duttaand A. S. Rathore, Analytical QbD: Development of a native gel electrophoresis method for measurement of monoclonal antibody aggregates, Electrophoresis, 35 (2014) 2163-2171.
129. M. A. Shaik, A. Dhakre, N. Patil and A. S. Rathore, Capacity Optimization and Scheduling of a Multiproduct Manufacturing Facility for Biotech Therapeutic Products, Biotechnology Progress, 30 (2014) 1221-1230.
130. A. S. Rathore, S. Mittal, M. Pathak and A. Arora, Guidance for Performing Multivariate Data Analysis of Bioprocessing Data: Pitfalls and Recommendations, Biotechnology Progress, 30 (2014) 967-973.
131. A. S. Rathore and R. Bhambure, Establishing Analytical Comparability for “Biosimilars”: Filgrastim as a Case Study, Analytical and Bioanalytical Chemistry, (2014) 406:6569-6576.
132. A. H. Mollah, H. S. Baseman, M. Long, and A. S. Rathore, A Practical Discussion of Risk Management for Manufacturing of Pharmaceutical Products, PDA J Sci Tech, 68 (2014) 271-280.
133. A. S. Rathore and R. Bhambure, High Throughput Process Development: I. Process Chromatography, Methods in Molecular Biology, 1129 (2014) 29-37.
134. A. S. Rathore and R. Bhambure, Aqueous Two Phase Assisted Precipitation of Proteins: A Platform for Isolation of Process Related Impurities from Therapeutic Proteins, Methods in Molecular Biology, 1129 (2014) 101-110.
135. A. S. Rathore and S. Muthukumar, High Throughput Process Development: II. Membrane Chromatography, Methods in Molecular Biology, 1129 (2014) 39-44.
136. A. S. Rathore, V. Kumar, A. Arora, S. Lute, K. Brorson, and A. Shukla, Mechanistic modeling of viral filtration, Journal of Membrane Science, 458 (2014) 96-103.
137. M. Pathak, N. Chaudharyand A. S. Rathore, Development of a low-cost, high-throughput native polyacrylamide gel electrophoresis (N-PAGE) protocol for lipoprotein sub-fractionation using Quality by Design approach, Journal of Pharmaceutical and Biomedical Analysis, 92 (2014) 119-126.
138. V. Halan, S. Maity, A. S. Rathore andI. S. Krull,Fluorescence-Detection Size- Exclusion Chromatography —An Analytical Technique with Multiple Applications, LC GC North America, December 2014.
139. R. Bhambure, I. Sharma, S. K. Pattanayekand A. S. Rathore, Qualitative and Quantitative Examination of Non-Specific Protein Adsorption on Filter Membrane Disks of a Commercially available High Throughput Chromatography Device, Journal of Membrane Science, 451 (2014) 312-318.
140. V. Kumar, A. Bhalla, and A. S. Rathore, Design of Experiments Application in Bioprocessing: Concepts and Approach, Biotechnology Progress, 30 (2014) 86-99.
141. A. S. Rathore, P. Bade, V. Joshi, M. Pathak, S. K. Pattanayek, Refolding of Biotech Therapeutic Proteins Expressed in Bacteria: Review, J Chem Technol Biotechnol, 88 (2013) 1794-1806. 
142. A. S. Rathore, V. Kumar, N. Tugcuand R. Godavarti, Evolution of the Monoclonal Antibody Platform, BioPharm International, 2013, November.
143. V. Joshi, V. Kumar, A. S. Rathore, and I.S. Krull, A Rapid HPLC Method for Enabling PAT Application for Processing of GCSF, LC GC North America, September, 2013.
144. R. Bhambure, D. Guptaand A. S. Rathore, A Novel Multimodal Chromatography based Single Step Purification Process for Efficient Manufacturing of an E. coli based Biotherapeutic Protein Product, Journal of Chromatography A, 1314 (2013) 188-198.
145. S. Kabra, M. A. Shaik, and A. S. Rathore, Multi-period scheduling of a multi-stage multi-product bio-pharmaceutical process, Computers and Chemical Engineering, 57 (2013) 95-103.
146. A. H. Mollah, S. Bozzone, and A. S. Rathore, Process Lifecycle Validation: Applying Risk Management, BioPharm International, 2013, August.
147. B. Vashishta, M. Garg, R. Chaudhary, H. Sahni, R. Khanna, and A. S. Rathore, Use of Computational Fluid Dynamics for Development and Scale-up if a Helical Coil Heat Exchanger for Dissolution of a Thermally Labile API, Organic Process and Product Development, 17 (2013) 1311-1319.
148. R. Bhambure, R. Sharma, D. Guptaand A. S. Rathore, A Novel Aqueous Two Phase Assisted Platform for Efficient Removal of Process Related Impurities Associated with E. coli based Biotherapeutic Protein Products, Journal of Chromatography A, 1307 (2013) 49-57.
149. A. S. Rathore, V. Joshiand N. Yadav, Aggregation of Monoclonal Antibody Products: Formation and Removal, BioPharm International, 2013, March.
150. S. Muthukumarand A. S. Rathore, High Throughput Process Development (HTPD) Platform for Membrane Chromatography, Journal of Membrane Science, 442 (2013) 245-253.
151. R. Bhambureand A. S. Rathore, Chromatography Process Development in the QbD Paradigm I. Establishing a High Throughput Process Development (HTPD) Platform as a Tool for Establishing “Characterization Space” for an Ion Exchange Chromatography Step, Biotechnology Progress, 29 (2013) 403-414.
152. A. Persad, V. Chopda, A. S. Rathore, J. Gomes. Comparative Performance of Decoupled Input-Output Linearizing Controller and Linear Interpolation PID Controller: Enhancing Biomass and Ethanol Production by Saccharomyces cerevisiae, Applied Biochemistry and Biotechnology, 169 (2013) 1219-1240. 
153. A. S. Rathore, S. Mittal, S. Lute, K. Brorson, Chemometrics Applications in Biotech Processes: Predicting Column Integrity and Impurity Clearance during Reuse of Chromatography Resin, Biotechnology Progress, 28 (2013) 1308-1314. 
154. A. S. Rathore and V. Joshi, Scale-down of Biopharmaceutical Purification Operations, Encyclopedia of Industrial Biotechnology: Bioprocess, Bioseparation, and Cell Technology, (2013), DOI: 10.1002/9780470054581.eib653.
155. A. S. Rathore and G. Kapoor, Process Analytical Technology: Strategies for Biopharmaceuticals, Encyclopedia of Industrial Biotechnology: Bioprocess, Bioseparation, and Cell Technology, (2013), DOI: 10.1002/9780470054581.eib652.
156. P. Bade, S. P. Kotu, A. S. Rathore, Optimization of the Refolding Process for a Therapeutic Fusion Protein in a Quality by Design (QbD) Paradigm, Journal of Separation Science, 35 (2012) 3160-3169. 
157. A. Guttman, A. S. Rathore, and I.S. Krull, Bioanalytical Tools for the Characterization of Biologics and Biosimilars, LC GC North America, May, 2012.
158. A. S. Rathore, C. Sharma and A. Persad, Computational Fluid Dynamics (CFD) as a Tool for establishing Design Space for Mixing in a Bioreactor, Biotechnology Progress, 28 (2012) 382-391.
159. A. S. Rathore, S. Jadhav, M. Bhalghat, S. Kandawalla, S. Ray, A. K. Patra, Key Considerations for Development and Production of Vaccine Products, BioPharm International, March, 2012.
160. N. Bhushan, S. Hadpe and A. S. Rathore, Chemometrics Applications in Biotech Processes: Assessing Process Comparability, Biotechnology Progress, 28 (2012) 121-128. 
161. A. S. Rathore, A. Bansal and J. Hans, Knowledge Management and Process Monitoring of Biopharmaceutical Processes in the Quality by Design Paradigm, in Measurement, Monitoring, Modelling and Control, Ed. C.-F. Mandenius and N. T. Hooker, Springer Verlag, 2013 (132) 217-247.
162. R. Mendhe, I.S. Krull, and A. S. Rathore, Analytical Tools for Enabling Process Analytical Technology Applications in Biotechnology, LC GC North America, January, 2011. Pharm. Tech., November, 2012.
163. V. Joshi, V. Kumar, A. S. Rathore, and I.S. Krull, A Rapid HPLC Method for Enabling PAT Application for Processing of GCSF, LC GC North America, September, 2013.
164. S. Kreimer, J. Champagne, A. S. Rathore, and I.S. Krull, The Use of Light-Scattering Detection with SEC and HPLC for Protein and Antibody Studies, Part II: Examples and Comparison to Mass Spectrometry, LC GC North America, December, 2012.
165. S. Kreimer, A. S. Rathore, and I.S. Krull, The Use of Light-Scattering Detection with SEC and HPLC for Protein and Antibody Studies, Part I: Background, Theory, and Potential Uses, LC GC North America, September, 2012.
166. A. S. Rathore, Development and Commercialization of Biosimilars in India, BioPharm International, November, 2011.
167. A. S. Rathore, N. Bhushan andS. Hadpe,Use of Multivariate Data Analysis (MVDA) for Generating Process Understanding from Manufacturing Data of Biotech Processes, Proceedings of the Indian National Science Academy, 77 (2011) 133-142. 
168. C. Sharma, D. Malhotra and A. S. Rathore, Computational Fluid Dynamics (CFD) Applications in Biotechnology Processes - Review, Biotechnology Progress, 2011, 27 (6) 1497-1510.
169. A. S. Rathore and A. Shirke, Recent Developments in Membrane-Based Separations in Biotechnology Processes – Review, PreparativeBiochemistry andBiotechnology, 41 (2011) 307-315.
170. A. S. Rathore, R. Bhambure, V. Ghare, Process Analytical Technology (PAT) for Bioseparation Unit Operations, in Process Analytical Technology Applied in Biopharmaceutical Process Development and Manufacturing, Ed. C. Undey, D. Low and J. M. C. de Menezes, Taylor and Francis, Boca Raton, pp 179-200, 2011.
171. I.S. Krull, A. S. Rathore, and Thomas E. Wheat, Current Applications of UHPLC in Biotechnology, Part I: Peptide Mapping and Amino Acid Analysis, LC GC North America, Part 1: September and Part 2: December, 2011. 
172. A. Bansal, J. Hans and A. S. Rathore, Operation Excellence: More Data or Smarter Approach?, BioPharm International, 2011, June.
173. A. S. Rathore, S. Hadpe and N. Bhushan, Chemometrics Applications in Biotech Processes: Review, Biotechnology Progress, 27 (2011) 307-315.
174. A. Shrivastava, S. Sakthivel, B. Pitchumaniand A. S. Rathore, Estimation of Significant Variables in Wet Attrition Milling – a Statistical Approach, Powder Technology, 211 (2011) 46-53.
175. I.S. Krull, A. S. Rathore, and S. Kreimer, SteveBiotechnology Highlights from IsrAnalytica 2011, LC GC North America, June, 2011.
176. T. Sengar and A. S. Rathore, Achieving Process Intensification by Scheduling and Debottlenecking Biotech Processes, BioPharm International, 2011, February.
177. A. S. Rathore, R. Bhambure and I. S. Krull, High Throughput Tools and Approaches for Development of Process Chromatography Steps, LC GC North America, March, 2011.
178. A. S. Rathore and D. A. LeBlanc, PDA’s New Technical Report for Biotech Cleaning Validation, BioPharm International, March, 2011.
179. A. S. Rathore, Quality by Design for Follow-on Biologics, Pharmaceutical Technology, February, 2011. 
180. R. Bhambure, K. Kumarand A. S. Rathore, High Throughput Process Development for Biopharmaceutical Products: Review, Trends in Biotechnology, 29 (2010) 127-135. 
181. I. S. Krulland A. S. Rathore, Popular Cell Expression Systems in the Biotechnology Industry, LC GC North America, 28 (2010) 800-809.
182. A. S. Rathore and I. S. Krull, Biosimilars: Introduction, Concerns and Opportunities, LC GC North America, 28 (2010) 598-600.
183. A. S. Rathore and D. Low, Implementation of QbD for Biotech Products: Managing Raw Materials, BioPharm International, 2010, part 1 – October and part 2 - November.
184. I. S. Krulland A. S. Rathore, Analytical Tools for Characterization of Biotechnology Products and Processes, LC GC North America, 29 (2010) 454.
185. A. S. Rathore, R. Bhambure and V. Ghare, Process Analytical Technology (PAT) for Biopharmaceutical Products, Anal. Bioanal. Chem., 398 (2010) 137-154.
186. A. S. Rathore, Quality by Design for manufacturing of biopharmaceuticals, BioSpectrum, 2010, April.
187. A. O. Kirdar, G. Chen and A. S. Rathore, Combining Near-Infrared (NIR) Spectroscopy and Multivariate Data Analysis (MVDA) for Screening of Raw Materials Used in the Cell Culture Medium for the Production of a Recombinant Therapeutic Protein, Biotechnol. Prog., 26 (2010) 527-531.
188. A. S. Rathore, L. Parr, S. Dermawan, K. Lawson and Y. Lu, Large Scale Demonstration of Process Analytical Technology (PAT) in Bioprocessing: Use of High Performance Liquid Chromatography (HPLC) for Making Real Time Pooling Decisions for Process Chromatography, Biotechnol. Prog., 26 (2010) 448-457.
189. A. S. Rathore, Quality by Design for Biotechnology Products: Challenges and Solutions, Pharmaceutical Technology Europe, 2010, February, 4.
190. A. S. Rathore, Setting Specifications for a Biotech Therapeutic Product in the Quality by Design Paradigm, BioPharm International, January, 2010, 46-53.
191. E. K. Read, J. T. Park, R. B. Shah, B. S. Riley, K. A. Brorson, and A. S. Rathore, Process Analytical Technology (PAT) for Biopharmaceutical Products: Concepts and Applications – Part I, Biotechnology Bioengineering, 105, 2010, 276-284.
192. E. K. Read, J. T. Park, R. B. Shah, B. S. Riley, K. A. Brorson, and A. S. Rathore, Process Analytical Technology (PAT) for Biopharmaceutical Products: Concepts and Applications – Part II, Biotechnology Bioengineering, 105, 2010, 285-295.
193. T. Arora et al, Quality by Design for Biotechnology Products, BioPharm Intl., Part 1: November, 2009, 26-36; Part 2: December, 2009, 42-58; Part 3: January, 2010, 36-45.
194. A. S. Rathore, Follow-on Protein Products: Scientific Issues, Developments and Challenges, Trends in Biotechnology, 27, 2009, 698-705.
195. B. S. Kendrick, G. Chrimes, S. L. Cockrill, J. P. Gabrielson, K. K. Arthur, B. D. Prater, Q. Qin, B. Zhang and A. S. Rathore, Analytical Tools for Product and Process Characterization, BioPharm Intl., August, 2009, 32-44.
196. A. S. Rathore, X. Li, W. Bartkowski, A. Sharma, and Y. Lu, Case Study and Application of Process Analytical Technology (PAT) towards Bioprocessing: III. Use of Tryptophan Fluorescence as At-line Tool for Making Pooling Decisions for Process Chromatography, Biotech. Prog., 25, 2009, 1433-1439.
197. A. S. Rathore, A Roadmap for Implementation of Quality by Design (QbD) for Biotechnology Products, Trends in Biotechnology, 27, 2009, 546-553.
198. S. K. Singh, N. Rathore, A. McAuley and A. S. Rathore, Formulation and Manufacturing of Biotech Drug Products: Issues and Best Practices, BioPharm Intl., June (2009) 32-49.
199. P. Konold, R. Woolfenden II, Cenk Undey and A. S. Rathore, Monitoring of Biopharmaceutical Processes: Present and Future Approaches, BioPharm Intl., May (2009) 26-39.
200. D. M. Boyle, J. J. Buckley, G. V. Johnson, A. S. Rathore, and M. G. Gustafson., Use of Design of Experiments (DOE) for Development of Refold Technology for Progenipoietin-1, A Recombinant Human Cytokine Fusion Protein from E. coli Inclusion Bodies, Biotechnol. Appl. Biochem., 54 (2009) 85-92.
201. X. Liu, M. Collins, N. Fraud, J. Campbell, I. Lowenstein, K. M. Lacki and A. S. Rathore, Upcoming Technologies to Facilitate More Efficient Manufacturing of Biologics, BioPharm Intl., February, 2009, 38-51.
202. A. S. Rathore, Application of Process Analytical Technology (PAT) towards Bioprocessing,  American Pharmaceutical Review, March/April (2009) 60-62.
203. R. Mhatre and A. S. Rathore, Quality by Design (QbD) – an overview of the basic concepts, in Quality by Design for Biopharmaceuticals: Perspectives and Case Studies, Ed. A. S. Rathore and R. Mhatre, Wiley Interscience, New Jersey, 2009, 1-8.
204. P. van Hoek, J. Harms, X. Wang, and A. S. Rathore, Case Study on Definition of Design Space for a Microbial Fermentation Step, in Quality by Design for Biopharmaceuticals: Perspectives and Case Studies, Ed. by A. S. Rathore and R. Mhatre, Wiley Interscience, New Jersey, 2009, 85-109.
205. A. S. Rathore, Process Analytical Technology (PAT): Application in Manufacturing of Biologics, Quality for Biologics, BioPharm Knowledge Publishing, (2009) 39-53.
206. A. S. Rathore and H. Winkle, Quality by Design for Biopharmaceuticals: Regulatory Perspective and Approach, Nature Biotechnology, 27 (2009) 26-34.
207. A. S. Rathore, A. Saleki-Gerhardt, S. H. Montgomery, and S. M. Tyler, Quality by Design for Pharmaceuticals: Industrial Case Studies on Defining and Implementing Design Space for the Process, BioPharm Intl., Part 1: December (2008) and Part 2: January (2009).
208. A. S. Rathore and R. Devine, Quality by Design for Pharmaceuticals: Concepts and Implementation, PDA Journal of Science and Technology, 62 (2008) 380-390.
209. O. Kaltenbrunner, J. McCue, J. M. Mollerup and A. S. Rathore, Modeling of Biopharmaceutical Processes: II. Process Chromatography Unit Operation, BioPharm, 21(2008) 28-42.
210. A. S. Rathore, R. Wood, A. Sharma, and S. Dermawan Case Study and Application of Process Analytical Technology (PAT) towards Bioprocessing: II. Use of Ultra Performance Liquid Chromatography (UPLC) for Making Real Time Pooling Decisions for Process Chromatography, Biotech. Bioengg., 101 (2008) 1366-1374.
211. A. O. Kirdar, K. D. Green and A. S. Rathore, Application of Multivariate Analysis for Identification and Resolution of a Root Cause for a Bioprocessing Application, Biotech. Prog., 24 (2008) 720-726.
212. J. Harms, X. Wang, T. Kim, J. Yang, and A. S. Rathore, Defining Design Space for Biotech Products: Case Study of Pichia pastoris Fermentation, Biotech. Prog., 24 (2008) 655-662.
213. A. S. Rathore, M. Yu, S. Yeboah, and A. Sharma, Case Study and Application of Process Analytical Technology (PAT) towards Bioprocessing: Use of On-Line High Performance Liquid Chromatography (HPLC) for Making Real Time Pooling Decisions for Process Chromatography, Biotech. Bioengg., 100 (2008) 306-316.
214. G. Nyberg, K. Green, Y. Hashimura and A. S. Rathore, Modeling of Biopharmaceutical Processes: I. Microbial and Mammalian Unit Operations, BioPharm, June, 2008, 56-65.
215. A. Sharma, S. Anderson and A. S. Rathore, Filter Clogging Issues in Sterile Filtration, BioPharm, April, 2008, 53-57.
216. R. Johnson, O. Yu, A. Kirdar, A. Annamalai, S. Ahuja, K. Ram and A. S. Rathore, Applications of Multivariate Data Analysis (MVDA) for Biotech Processing, BioPharm, 20 (2007) 130-144.
217. R. Samavedam, R. Morrison, T. Kichefski, S. Cote and A. S. Rathore, Lifetime Studies for Membrane Reuse: Principles and Case Study, BioPharm, September, 2007.
218. Y. Xiao, A. S. Rathore, J. P. O’Donnell, E. J. Fernandez, Generalizing a Two Conformation Model for Describing Salt and Temperature Effects on Protein Retention and Stability in Hydrophobic Interaction Chromatography, J. Chromatogr. A, 1157 (2007) 197-206.
219. A. S. Rathore, R. Branning and D. Cecchini, Design Space for Biotech Products, BioPharm, April, 2007, 36-40.
220. X. Wang, A. Germansderfer, J. Harms and A. S. Rathore, Using Statistical Analysis for Setting Process Validation Acceptance Criteria for Biotech Products, Biotech. Prog., 23 (2007) 55-60.
221. A. O. Kirdar, J. S. Conner, J. Baclaski, and A. S. Rathore, Application of Multivariate Analysis towards Biotech Processes: Case Study of a Cell-Culture Unit Operation, Biotech. Prog., 23 (2007)  61-67.
222. A. S. Rathore and M. Karpen, Economic Analysis as a Tool for Process Development: Harvest of a High Cell Density Fermentation, BioPharm, November, 2006.
223. A. S. Rathore, A. Sharma and D. Chillin, Applying Process Analytical Technology to Biotech Unit Operations, BioPharm, August, 2006, 48-57.
224. E. Russell, A. Wang, and A. S. Rathore, Harvest of a Therapeutic Protein Product from High Cell Density Fermentation Broths:  Principles and Case Study, in Process Scale Bioseparations for the Biopharmaceutical Industry, Ed. by A. A. Shukla, M. Etzel, and S. Gadam, CRC Press, 2006, 1-58.
225. B. Channer, G. G. Skellern, M. R. Euerby, A. P. McKeown, and A. S. Rathore, Retention Behavior of Charged Analytes in Voltage Assisted Micro-HPLC, J. Chromatogr., 1095 (2005) 172-179.
226. J. Moscariello, E. Lightfoot, and A. S. Rathore, Efficiency Measurements for Chromatography Columns, BioPharm, August, 2005.
227. A. Wang, R. Lewus, and A. S. Rathore, Comparison of Different Options for Harvest of a Therapeutic Protein Product for High Cell Density Fermentation Broth, Biotech. Bioengg, 94 (2005) 91-104.
228. A. S. Rathore, R. Krishnan, S. Tozer, S. Rausch and J. Seely, Optimization, Guidelines and Examples for Scale-down of Biopharmaceutical Unit Operations, – Part I, BioPharm, March, 2005; Part II, BioPharm, April, 2005. Part 1, Pharmaceutical Technology Europe, April (2006) 51-57. Part 2, Pharmaceutical Technology Europe, July (2006) 28-32.
229. A. S. Rathore, Y. Li and J. Wilkins, Use of Electrokinetic Measurements for Characterization of Monolithic Columns uses in Capillary Electrochromatography, J. Chromatogr. A, 1079 (2005) 299-306.
230. A. S. Rathore and G. Sofer, Lifespan studies for Chromatography and Filtration Media, in Process Validation, Ed. by A. S. Rathore and G. Sofer, Marcel Dekker, 2005, 169-203.
231. A. S. Rathore, Process Optimization and Characterization Studies for Purification of an E. coli Expressed Protein Product, in Process Validation, Ed. by A. S. Rathore and G. Sofer, Marcel Dekker, 2005, 451-468.
232. A. S. Rathore, A. Wang, M. Menon, F. Riske, J. Campbell, E. Goodrich, and J. Martin, Optimization, Scale-up and Validation Issues in Filtration of Biopharmaceuticals – Part I, BioPharm, August, 2004; Part II, BioPharm, September (2004) 42-50.
233. A. S. Rathore, H. Levine, P. Latham, J. Curling, and O. Kaltenbrunner, Costing Issues in Production of Biopharmaceuticals, BioPharm, February, 2004.
234. A. S. Rathore, Joule Heating and Determination of Temperature in Capillary Electrophoresis and Capillary Electrochromatography Columns:  Review, J. Chromatogr., 1037 (2004) 431-443. 
235. A. S. Rathore, Migration of Sample Components in Capillary Analytical Techniques: Chromatography, Electrophoresis, and Electrochromatography, in Electrokinetic Phenomena, Ed. by A. S. Rathore and A. Guttman, Marcel Dekker, 2003, 1-14. 
236. E. Wen, A. S. Rathore, and Cs. Horváth, Electrosmotic Mobility and Conductivity in Microchannels, in Electrokinetic Phenomena, Ed. by A. S. Rathore and A. Guttman, Marcel Dekker, 2003, 141-166. 
237. A. S. Rathore, R. E. Bilbrey, and D. E. Steinmeyer, Optimization of an Osmotic Shock Procedure for Isolation of a Protein Product Expressed in E. coli, Biotech. Prog., 19 (2003) 1541-1546. 
238. A. S. Rathore, A. P. McKeown, and M. R. Euerby, Interplay of Chromatographic and Electrophoretic Processes in Capillary Electrochromatography, J. Chromatogr., 1010 (2003) 105-111. 
239. A. S. Rathore, S. E. Sobacke, T. J. Kocot, D. R. Morgan, R. L. Dufield, and N. M. Mozier, Analysis for Residual Host Cell Proteins and DNA in Process Streams of a Recombinant Protein Product Expressed in E. coli Cells, J. Pharm. Biomed. Anal., 32 (2003) 1199-1211.
240. A. S. Rathore, Qualification of a Chromatographic Column: Why and How to Do it, Biopharm, March (2003) 30-40; Pharmaceutical Technology Europe, March (2003) 45-56.
241. A. S. Rathore and A. Velayudhan, Scale-up Guidelines for Preparative Chromatography, BioPharm, January (2003) 34-42.
242. G. V. Annathur, J. L. Pierce, R. G. Combs, A. S. Rathore, and D. E. Steinmeyer, Improvements in Spinner Flask Designs for Insect Cell Suspension Culture, Biotechnol. Appl. Biochem., 38 (2003) 15-18.
243. A. S. Rathore, G. V. Johnson, J. J. Buckley, D. M. Boyle, and M. E. Gustafson, Process  Characterization of the Chromatographic Steps in the Purification Process of a Recombinant E.     coli Expressed Protein, Biotechnol. Appl. Biochem., 37 (2002) 51-61.
244. A. S. Rathore, Theory of Electroosmotic Flow, Retention and Separation Efficiency in Capillary Electrochromatography: Review, Electrophoresis, 23 (2002) 3827-3846. 
245. A. S. Rathore, J. F. Noferi, E. R. Arling, G. Sofer, P. Watler, and R. O’Leary, Process Validation: How Much and When, BioPharm, October, 2002, 18-+.
246. A. S. Rathore, K. Reynolds, and L. A. Colon, Effects of joule heating on conductivity in capillary electrophoresis and electrochromatography, Electrophoresis, 23 (2002) 2918-2928.  
247. A. S. Rathore, R. R. Kurumbail, and A. V. Lasdun, Requirements for validating a capillary isoelectric focusing method for impurity quantitation, LC-GC, November, 2002, 1042-+. 
248. A. S. Rathore, Chromatography process development for purification of a recombinant E. coli expressed protein, in Scale-up and Optimization in Preparative Chromatography, Ed. by A. S. Rathore and A. Velayudhan, Marcel Dekker, 2002, 317-338. 
249. A. S. Rathore and A. Velayudhan, An Overview of Scale-Up in Preparative Chromatography”, in Scale-up and Optimization in Preparative Chromatography, Ed. by A. S. Rathore and A. Velayudhan, Marcel Dekker, 2002, 1-32.
250. A. S. Rathore and Cs. Horváth, Chromatographic and electrophoretic migration parameters in capillary electrochromatography, Electrophoresis, 23 (2002) 1211-1216.
251. E. Wen, A. S. Rathore, and Cs. Horváth, Enhancement of electosmotic flow in capillary electrochromatography, Electrophoresis, 22 (2001) 3720-3727.
252. A. S. Rathore and Cs. Horváth, Migration of charged sample components and electroosmotic flow in packed capillary columns, in Capillary Electrochromatography, Ed. by Z. Deyl and F. Svec, Elsevier, 1-38, 2001.
253. A. V. Lasdun, R. R. Kurumbail, and A. S. Rathore, Validability of an capillary isoelectric focusing method for impurity quantitation, J. Chromatogr., 917 (2001) 147-158. 
254. A. S. Rathore, Resin screening for optimization of chromatographic separations, LC GC, 19 (2001)  616-622.
255. A. S. Rathore, E. Wen, and Cs. Horváth, Electosmotic mobility and conductivity in columns for capillary electrochromatography, Anal. Chem., 71 (1999) 2633-2641.
256. A. S. Rathore and Cs. Horváth, Cyclodextrins as selectivity enhancers in capillary zone electrophoresis of proteins, Electrophoresis, 19 (1998) 2285-2289.
257. A. S. Rathore and Cs. Horváth, Axial nonuniformities and flow in columns for capillary electrochromatography, Anal. Chem., 70 (1998) 3069-3077.
258. A. S. Rathore and Cs. Horváth, “Effect of a pre-detection open segment in the column on the speed and selectivity in capillary electrochromatography,” Anal. Chem., 70 (1998) 3271-3274.
259. A. S. Rathore and Cs. Horváth, Cyclodextrin aided separation of peptides and proteins by capillary zone electrophoresis, J. Chromatogr. A, 796 (1998) 367-373.
260. A. S. Rathore and Cs. Horváth, CZE of interconverting cis-trans conformers of peptidyl proline dipeptides: estimation of the kinetic parameters, Electrophoresis, 18 (1997) 2935-2943.
261. A. S. Rathore and Cs. Horváth, Capillary electrochromatography - theories of electroosmotic flow in porous media, J. Chromatogr. A, 781 (1997) 185-195.
262. A. S. Rathore and Cs. Horváth, Displacement chromatography with on-column isomerization, J. Chromatogr. A, 787 (1997) 1-12.
263. F. Thunecke, A. Kalman, F. Kalman, S. Ma, A. S. Rathore and Cs. Horváth, Kinetic study on cis-trans isomerization of peptidyl proline peptides, J. Chromatogr. A, 744 (1996) 2259-2272.
264. A. S. Rathore and Cs. Horváth, Separation parameters via virtual migration distances in HPLC and CZE and electrokinetic chromatography, J. Chromatogr. A, 743 (1996) 231-246.
265. K. B. Ramachandran, A. S. Rathore and S. K. Gupta, Modeling the effects of electrostatic            interaction with reaction-generated pH change on the kinetics of immobilized enzymes, Chem. Eng. Journal, 57 (1995) B15-B21.

LECTURES

1. A. S. Rathore, “Challenges with Development of Biotech Therapeutics”, Invited talk, ETH Zurich, Zurich, Switzerland, June, 2019.
2. A. S. Rathore, “Non-protein A purification platform for continuous processing of monoclonal antibody therapeutics”, 255th ACS National Meeting, Orlando, USA, April, 2019.
3. A. S. Rathore, “Continuous processing of biotech therapeutics Ð enabling case studies”, Keynote Lecture, 255th ACS National Meeting, Orlando, USA, April, 2019.
4. A. S. Rathore, “Role of mechanistic modeling in optimization and control of bioseparation processes”, 255th ACS National Meeting, Orlando, USA, April, 2019.
5. A. S. Rathore, “Kinetics and characterization of non-enzymatic fragmentation of monoclonal antibody therapeutics”, 255th ACS National Meeting, Orlando, USA, April, 2019.
6. A. S. Rathore, “Multivariate data analysis for biotech processes: Industrial case studies”, 255th ACS National Meeting, Orlando, USA, April, 2019.
7. A. S. Rathore, “Model Based Control of Biotechnology Processes”, Biotherapeutics and Vaccines Development, Gordon Research Conference, Houston, USA, January, 2019.
8. A. S. Rathore, “Model Based Process Control for Production of Biopharmaceuticals”, Keynote talk, Bioprocessing India 2018, New Delhi, India, December 2018.
9. A. S. Rathore, “Implementation of QbD for Biopharmaceuticals: Tools and Case Studies”, Keynote talk, Bioprocessing Asia 2018, Langkawi, Malaysia, November 2018.
10. A. S. Rathore, “Challenges in Development and Commercialization of Biotech Therapeutics”, Invited talk, Jamia Millia Islamia, New Delhi, October 2018.
11. A. S. Rathore, “Role of Modeling in Optimization and Control of Bioseparation Processes”, Keynote Lecture, European Society of Biochemical Engineering Sciences (ESBES) 2018, Lisbon, Portugal, September, 2018.  
12. A. S. Rathore, “Quality by Design for Production of Biopharmaceuticals”, Workshop at the University of Massachusetts Lowell, Lowell, USA, August 2018.
13. A. S. Rathore, “QbD, PAT, QRM for Production of Pharmaceuticals”, Workshop with DSM Sinochem, Kuala Lumpur, Malaysia, June 2018.
14. A. S. Rathore, “Role of Mechanistic Modeling in Process Control and Implementation of Quality by Design for Production of Biopharmaceuticals”, Invited talk, Austrian Center for Biotechnology, Vienna, Austria, June, 2018.
15. A. S. Rathore, “QbD, PAT, QRM for Production of Pharmaceuticals”, Workshop with DSM Sinochem, Bangkok, Thailand, May 2018.
16. A. S. Rathore, “Challenges with Development of Biosimilars”, Invited talk, Indian Institute of Technology Mumbai, Mumbai, April 2018.
17. A. S. Rathore, “Development and Commercialization of Biosimilar Products: Challenges and Opportunities”, Invited talk, BioEpoch-2018, New Delhi, India, April 2018.
18. A. S. Rathore, “QbD, PAT, QRM for Production of Pharmaceuticals”, Workshop with DSM Sinochem, Manila, Philippines, April 2018.
19. A. S. Rathore, "Role of Mechanistic Modeling in Optimization and Control of Bioseparation Processes”, Bioprocessing India 2017, Guwahati, India, December, 2017.
20. A. S. Rathore, “Role of Mechanistic Modeling in Process Control and Implementation of Quality by Design for Production of Biopharmaceuticals”, Invited talk, Biocon Ltd, December, 2017
21. A. S. Rathore, “Challenges with Development of Biotech Therapeutics”, Invited talk, Institute of Microbial Technology, Mohali, November 2017
22. A. S. Rathore, “QbD, PAT, QRM for Production of Pharmaceuticals”, Workshop with DSM Sinochem, Jakarta, Indonesia, October 2017.
23. A. S. Rathore, “Implementation of QbD and PAT in Biopharmaceutical Processes”, Invited talk, Hanyang University, Seoul, South Korea, September, 2017.  
24. A. S. Rathore, “Process Validation, Risk Management and Process Characterization”, Workshop with Kbio, Seoul, South Korea, September, 2017.  
25. A. S. Rathore, “Pharmacoeconomic Impact of Biosimilars”, Invited Lecture, FIP World Congress of Pharmacy & Pharmaceutical Sciences, Seoul, South Korea, September, 2017.  
26. A. S. Rathore, “QbD, PAT, QRM for Production of Pharmaceuticals”, Workshop with DSM Sinochem, Dubai, UAE, July 2017.
27. A. S. Rathore, “Quality by Design and Process Analytical Technology”, Workshop with Kbio, Seoul, South Korea, June, 2017.  
28. A. S. Rathore, “Scientific and Regulatory Challenges in Development and Commercialization of Biosimilars”, Invited Lecture, Global BioConference (GBC), Seoul, South Korea, June, 2017.  
29. A. S. Rathore, “Challenges with Development of Biotech Therapeutics”, Invited talk, Banaras Hindu University, Varanasi, June 2017
30. A. S. Rathore, “Application of Process Analytical Technology and Advanced Controls for Manufacturing”, Johnson and Johnson, Pomezia, Italy, May, 2017.  
31. A. S. Rathore, “QbD, PAT, QRM for Production of Pharmaceuticals”, Workshop with DSM Sinochem, Ho Chi Minh City, Vietnam, May 2017.
32. A. S. Rathore, “Implementation of Quality by Design for Processing of Food Products and Biotherapeutics”, Invited Lecture, Food and Biosystems Engineering (FABE), Rhodes, Greece, May, 2017.  
33. A. S. Rathore, “Integrated Continuous Processing of Proteins Expressed as Inclusion Bodies”, Keynote Lecture, 253rd ACS National Meeting, San Francisco, USA, April, 2017.
34. A. S. Rathore, “Multivariate Data Analysis for Biotech Processes: Industrial Case Studies”, Keynote Lecture, 253rd ACS National Meeting, San Francisco, USA, April, 2017.
35. A. S. Rathore, “Continuous Processing of Biotech Therapeutics – Enabling Case Studies”, Invited talk, 3rd Annual Biologics Manufacturing India 2017, Pune, India, February 2017.
36. A. S. Rathore, "Continuous processing in biopharma manufacturing”, Bioprocessing India 2016, Mohali, India, December, 2016.
37. A. S. Rathore, “Workshop on Methods for Accelerating Scalable Bioprocess Development”, Workshop co-organized with Prof. Christoph Herwig, Technical University of Vienna, Vienna, Austria, November, 2016.
38. A. S. Rathore, "A Masterclass in QbD, QRM and PAT for Bioprocessing Applications”, with Pall Life Sciences, Boston, USA, October, 2016.
39. A. S. Rathore, “Industry Implementation of Continuous Manufacturing for Biotherapeutics: Passing Trend or Fundamental Shift?”, Invited talk, University College London, UK,  September, 2016.
40. A. S. Rathore, “Technology Drivers for Implementation of QbD and PAT in Biopharmaceutical Processes”, Invited talk, Newcastle University, UK, September, 2016.
41. A. S. Rathore, “Recent Trends in the Biopharmaceutical Industry”, Invited talk, BioPharma Solutions Workshop, Bangalore, India, August 2016.
42. A. S. Rathore, “QbD, PAT, QRM for Production of Pharmaceuticals”, Workshop with DSM Sinochem, Cairo, Egypt, July 2016
43. A. S. Rathore, “QbD, PAT, QRM for Production of Pharmaceuticals”, Workshop with DSM Sinochem, Alexandria, Egypt, July 2016
44. A. S. Rathore, "Quality by Design for Manufacturing of Biopharmaceuticals”, with Pall Life Sciences, Boston, USA, May, 2016.
45. A. S. Rathore, “Discussing the application of PAT at the development level for robust processes and consistent quality”, Invited talk, CPhI’s Process Analytical Technology Workshop, Hyderabad, India, April 2016.
46. A. S. Rathore, “Development and Commercialization of Biosimilar Products in India: Industrial Challenges and Opportunities”, Invited talk, BiTERM 2016, New Delhi, India, April 2016.
47. A. S. Rathore, “Aseptic Processing for Production of Pharmaceuticals: QbD, PAT, QRM and Validation”, Workshop with DSM Sinochem, Bangkok, Thailand, March 2016.
48. A. S. Rathore, “Development and Commercialization of Biosimilar Products: Challenges and Opportunities”, Invited talk, BioEpoch-2016, New Delhi, India, March 2016.
49. A. S. Rathore, "Enabling Continuous Processing for Production of Biotech Therapeutics”, Bioprocessing India 2015, Chennai, India, December, 2015.
50. A. S. Rathore, “Challenges with Development of Biotech Therapeutics”, Plenary Lecture, Targeted Proteomics Workshop and International Symposium, Mumbai, India, December, 2015
51. A. S. Rathore, “Enabling continuous processing of biotech therapeutics: Case Studies”, Invited talk, BioPharma India Convention 2015, November, 2015
52. A. S. Rathore, “Current and Emerging trends in the Biopharmaceutical Industry”, Invited talk, Biocon Limited, October, 2015
53. A. S. Rathore, "Quality by Design for Production of Biopharmaceuticals”, Short Course, Boston, October, 2015.
54. A. S. Rathore, “Aseptic Processing for Production of Pharmaceuticals: QbD, PAT, QRM and Validation”, CEP Workshop with DSM Sinochem, IIT Delhi, New Delhi, October 2015.
55. A. S. Rathore, “Challenges in Development and Commercialization of Biotech Therapeutics”, Invited talk, 1st Refresher Course in Course in Life Science & Biotechnology, UGC-Human Resource Development Centre, Jawaharlal Nehru University, New Delhi, August 2015.
56. A. S. Rathore, QbD, PAT, Downstream Processing, in Advanced Methods in Bioprocess Development, Workshop co-organized with Prof. Christoph Herwig, Technical University of Vienna, Vienna, Austria, June, 2015.
57. A. S. Rathore, “Continuous Processing of Biotech Therapeutics – Enabling Case Studies”, Invited Lecture, Biopartitioning and Purification Conference 2015, Vienna, Austria, June, 2015.
58. A. S. Rathore, “Regulatory Issues related to Approval of Biotech Therapeutics”, Invited talk, Tools and techniques in Biotechnology, BIRAC 1st BIG Conclave, New Delhi, May, 2015.
59. A. S. Rathore, “Implementation of QbD for Production of Biotech Therapeutics”, Invited talk, Tools and techniques in Biotechnology, Short Term Training Programme organized by MDU Rohtak, Rohtak, May, 2015.
60. A. S. Rathore, “Development and Commercialization of Biosimilar Products: Challenges and Opportunities”, Keynote Lecture, QbD in Pharma Development World Congress 2015, Chandigarh, India, April, 2015.
61. A. S. Rathore, “Development and Commercialization of Biosimilar Products: Challenges and Opportunities”, Keynote Lecture, 249th ACS National Meeting, Denver Colorado, March, 2015.
62. A. S. Rathore, “Implementation of QbD for Development of a Downstream Process for a Therapeutic Biosimilar”, Invited talk, 249th ACS National Meeting, Denver Colorado, March, 2015.
63. A. S. Rathore, “Comparison of PAT based Approaches for making Real-Time Pooling Decisions for Process Chromatography – use of Feed Forward Control”, Invited talk, 249th ACS National Meeting, Denver Colorado, March, 2015.
64. A. S. Rathore, “Development of PAT based monitoring & control platform for fermentation”, Invited talk, Challenges with Scale-up, cGMP Production and Data Processing Solutions from Applikon Biotechnology, Workshop from Applikon and Spinco, New Delhi, March, 2015.
65. A. S. Rathore, “Implementation of QbD and PAT for Production of Biotech Therapeutics”, Invited talk, Technical University of Vienna, Austria, December 2014.
66. A. S. Rathore, “Implementation of QbD for Biopharmaceuticals: Tools and Case Studies”, Bioprocessing India 2014, Mumbai, India, December 2014.
67. A. S. Rathore, “QbD based Process Development for Production of Biotech Therapeutics”, Invited talk, Denmark Technical University, Denmark, June 2014.
68. A. S. Rathore, “Implementation of QbD and PAT in Biopharmaceutical Processing”, Workshop, Pall Corporation, Portsmouth, UK, June 2014.
69. A. S. Rathore, “Creation of a Process Understanding of Chromatographic Performance Loss during Biotherapeutic Manufacture: A UK-India Partnership”, Invited talk, University College London, London, UK, June 2014.
70. A. S. Rathore, "Strategies for Accelerating Discovery to Early Stage Development”, Invited Talk, BIRAC 2nd Foundation Day, New Delhi, March, 2014.
71. A. S. Rathore, "Implementation of QbD for Biopharmaceuticals: Tools and Case Studies”, Keynote Speaker, PAT & QbD Forum, Goettingen, Germany, February, 2014.
72. A. S. Rathore, “Effective scale up, regulatory and standards implementation”, Invited talk, FITT Workshop on Strategizing IP Management & Biotech Commercialization, IIT Delhi, New Delhi, January, 2014.
73. A. S. Rathore, “Challenges in and Solutions for Purification of Biotech Therapeutics”, Asian Congress on Biotechnology 2013, New Delhi, India, December 2013
74. A. S. Rathore, "India Perspective: Recent Trends in the Regulation of Biopharmaceuticals”, Invited talk, CMC Forum Asia 2013, Tokyo, Japan, December, 2013. 
75. A. S. Rathore, "QbD based Process Development for Production of Biotech Therapeutics”, Bioprocessing India 2013, New Delhi, India, December, 2013.
76. A. S. Rathore, "Process Validation for Biopharmaceutical Products”, Invited talk, QbD Workshop by GE Healthcare, Tokyo, Japan, October, 2013.
77. A. S. Rathore, "Quality by Design: Risk Management and Assessment”, Invited talk, QbD Workshop by GE Healthcare, Tokyo, Japan, October, 2013.
78. A. S. Rathore, "Technology Transfer for Biopharmaceutical Products”, Invited talk, QbD Workshop by GE Healthcare, Tokyo, Japan, October, 2013.
79. A. S. Rathore, "Challenges in and Solutions in Bioprocessing”, Invited talk, Biodownstream Technology Course India, Vellore Institute of Technology, India, September, 2013.
80. A. S. Rathore, "Challenges in and Solutions for Purification of Biotech Therapeutics”, Invited talk, IIChE (NRC) Lecture Series, New Delhi, India, September, 2013.
81. A. S. Rathore, "Comparison with Global Biopharmaceuticals Standards”, Invited talk, BIRAC-CDSA Regulatory Meet: Demystifying Indian Regulations for Product Approvals, New Delhi, India, July, 2013.
82. A. S. Rathore, "Best Practices in Scale Up and Manufacturing”, Invited talk, BIRAC-CDSA Regulatory Meet: Demystifying Indian Regulations for Product Approvals, New Delhi, India, July, 2013.
83. A. S. Rathore, "Quality by Design for Biopharmaceuticals : An Update”, Invited talk, Pall Corporation, Bangalore, India, July, 2013.
84. A. S. Rathore, "Risk Management in Pharmaceutical Development”, Invited talk, Ranbaxy Limited, India, June, 2013.
85. A. S. Rathore, "Perspective on QbD based process development”, Invited talk, QbD Workshop by GE Healthcare, Mumbai, India, May, 2013.
86. A. S. Rathore, "Case Studies in QbD applications for downstream development”, Invited talk, QbD Workshop by GE Healthcare, Mumbai, India, May, 2013.
87. A. S. Rathore, "Comparability issues for biosimilars”, Invited talk, QbD Workshop by GE Healthcare, Mumbai, India, May, 2013.
88. A. S. Rathore et al, “Challenges in and Solutions for Purification of Biotech Therapeutics”, 245th ACS National Meeting, New Orleans, LA, April, 2013.
89. A. S. Rathore, “Comparability of Biosimilar Products -  Perspectives from the Indian Pharmacopeia Commission”, 2013 IPC-USP 12th Science & Standards Symposium, Delhi, India, April, 2013.
90. A. S. Rathore, "Establishing Product Comparability”, BIO-ABLE Biosimilars Regulatory Roundtable, New Delhi, March, 2013.
91. A. S. Rathore, "Global technological advances for process development and analytics of biosimilars”, 4th Annual Biosimilars India 2013, Mumbai, February, 2013.
92. A. S. Rathore, "Real time Experience in Filing and Seeking Approvals for New Drug/ INDs”, BIRAC - CDSA Regulatory Meet, New Delhi, February, 2013.
93. A. S. Rathore, "Comparability of Biosimilars – A Global Perspective”, Pharma-BioTECH World Conference 2013, Mumbai, January, 2013.
94. A. S. Rathore, "Product Comparability for Biosimilars”, Pharma-BioTECH World Conference 2013, Mumbai, January, 2013.
95. A. S. Rathore, "Risk Management in Quality by Design”, GE Healthcare Seminar, China, November, 2012.
96. A. S. Rathore, “Technology Transfer of Biotech Processes”, GE Healthcare Seminar, China, November, 2012.
97. A. S. Rathore, "Case Study 1: Development of Design Space for Upstream & Downstream Process”, GE Healthcare Seminar, China, November, 2012.
98. A. S. Rathore, "Process Validation”, Training of the SFDA, Government of China, Shanghai, China, July, 2012.
99. A. S. Rathore, "Quality by Design: Risk Management and Assessment”, Training of the SFDA, Government of China, Shanghai, China, July, 2012.
100. A. S. Rathore, "Production of Biosimilars in India: Challenges and Solutions”, Invited talk, Invictus Oncology, New Delhi, India, July, 2012.
101. A. S. Rathore, "Process Analytical Technology Applications for Biopharmaceutical Products”, Recovery of Biological Products XV, Stowe, USA, July, 2012.
102. A. S. Rathore, "Process Validation for Biopharmaceutials”, Invited talk, QbD Workshop by GE Healthcare, Lonza, Visp, Switzerland, June, 2012
103. A. S. Rathore, "Quality by Design for Biopharmaceuticals: Challenges and Solutions”, Invited talk, Lupin, Pune, India, March, 2012.
104. A. S. Rathore, "Trends in Process and Cleaning Validation”, Invited talk, QbD Workshop by GE Healthcare, Mumbai, India, February, 2012
105. A. S. Rathore, “Production of Biosimilars in India: Challenges and How IPC can Help”, 2012 IPC-USP 11th Science & Standards Symposium, Mumbai, India, February, 2012.
106. A. S. Rathore, "Trends in Process and Cleaning Validation”, Invited talk, QbD Workshop by GE Healthcare, Mumbai, India, February, 2012.
107. A. S. Rathore, “Role of Risk Assessment and Management in Implementation of Quality by Design (QbD) for Biopharmaceuticals”, Invited talk, QbD Workshop by GE Healthcare, Mumbai, India, February, 2012.
108. A. S. Rathore, "Technology Drivers for Implementation of Quality by Design for Biopharmaceuticals”, Invited talk, QbD Workshop by GE Healthcare, Mumbai, India, February, 2012.
109. A. S. Rathore, "Production of Biotech Products in India: Challenges and Solutions”, Invited talk, JSS College of Pharmacy, Mysore, December, 2011.
110. A. S. Rathore, "Production of Biotech Products in India: Challenges and Solutions”, Invited talk, JSS College of Pharmacy, Ooty, December, 2011.
111. A. S. Rathore, "Process Validation”, Training of the CDSCO, Drug Controller General of India, Government of India, Delhi, India, December, 2011.
112. A. S. Rathore, "Quality by Design: Risk Management and Assessment”, Training of the CDSCO, Drug Controller General of India, Government of India, Delhi, India, December, 2011.
113. A. S. Rathore, "Need for Cost and Time Efficient Commercialization of Biotech Therapeutics and Technology Drivers for Achieving It”, Keynote Lecture, EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies, University College of London, London, UK, November, December, 2011.
114. A. S. Rathore, "Quality by Design based Process Development and Validation”, Invited talk, GE Healthcare China, Shanghai, China, October, 2011.
115. A. S. Rathore and Patrick Swann “Quality by Design for Biopharmaceuticals: Concepts and Implementation”, PDA Training and Research Institute Course Series, Washington DC, USA, September, 2011
116. A. S. Rathore, "Quality by Design based Process Development”, Invited talk, Sartorius Stedim, Goettingen, Germany, May, 2011.
117. A. S. Rathore, "Challenges in and Solutions for Purification of Biotech Therapeutics”, Keynote Speaker, European Downstream Technology Forum, Goettingen, Germany, May, 2011.
118. A. S. Rathore, "Chromatographic Separations in Biotech Processes”, 5th International Workshop on Chromatographic Separation, Mixing, Filtration and Drying, Mumbai, India, April, 2011.
119. A. S. Rathore, “Challenges in Implementation of Quality by Design for Production of Biosimilars in India”, 2011 IPC-USP 10th Science & Standards Symposium, Hyderabad, India, February, 2011.
120. A. S. Rathore, "Challenges in Development and Commercialization of Biosimilars”, Invited talk, Export Inspection Council (EIC) India, New Delhi, India, January, 2011.
121. A. S. Rathore, "Challenges in Development and Commercialization of Biosimilars”, IPC-WHO Collaborative Workshop on Challenges and Opportunities in Compliance of Current Standards Prescribed in IP 2010, New Delhi, India, December, 2010.
122. A. S. Rathore, "High Throughput Downstream Technologies to Enable QbD Process Development”, Biologic Manufacturing World India, Mumbai, India, December, 2010
123. A. S. Rathore and Patrick Swann “Quality by Design for Biopharmaceuticals: Concepts and Implementation”, PDA Training and Research Institute Course Series, Washington DC, USA, September, 2010
124. A. S. Rathore, "Quality Risk Assessment and Management for Biotech Processes”, Interest Group Session on Quality Risk Management, 2010 PDA/FDA Joint Regulatory Conference, Washington DC, USA, September, 2010.
125. A. S. Rathore, "Scale-up, Technology Transfer and Process Validation of Biotech Processes in QbD Paradigm”, Invited talk, United States Food and Drug Administration (FDA), Silver Springs, MD, USA, September, 2010.
126. A. S. Rathore, "Quality by Design for Biopharmaceuticals”, Invited talk, GE Healthcare Course, Mumbai, June, 2010.
127. A. S. Rathore, "Role of Risk Assessment and Management in Implementation of Quality by Design”, Invited talk, PAT and Quality by Design for Biopharmaceuticals, London, United Kingdom, May, 2010.
128. A. S. Rathore, "Implementation of QbD for Biopharmaceuticals: Roadmap and Case Studies”, Invited talk, 6th Annual BioProcess International European Conference and Exhibition, Vienna, Austria, May 2010.
129. A. S. Rathore, "Implications of Quality by Design for a Biopharmaceutical Vendor”, Invited talk, GE Healthcare, Uppsala, Sweden, December, 2009.
130. A. S. Rathore, "Development and Commercialization of Biosimilar Products: Challenges and Opportunities”, Biologic India, Mumbai, India, December, 2009
131. A. S. Rathore, "Quality by Design for Biotechnology Products and Processes”, Invited talk for Food and Drug Administration (FDA),NIH Headquarters, Bethesda, MD, September, 2009
132. A. S. Rathore and Patrick Swann “Quality by Design for Biopharmaceuticals: Concepts and Implementation”, PDA Training and Research Institute Course Series, Washington DC, September, 2009
133. A. S. Rathore, "Technology Transfer of Pharmaceutical Processes: Issues and Solutions”, 2009 PDA/FDA Joint Regulatory Conference, Washington DC, September, 2009
134. A. S. Rathore, "Roadmap for Implementation of Quality by Design for Biopharmaceuticals”, Invited talk, Intas Biopharmaceuticals Limited, Ahmedabad, July, 2009.
135. A. S. Rathore, "Introduction to Quality by Design for Biotech Products”, Invited talk, Vical Corporation, San Diego, June, 2009.
136. A. S. Rathore and Gail Sofer “Process Validation for Biopharmaceuticals”, PDA Training and Research Institute Course Series, San Diego, February, 2009
137. A. S. Rathore, “Application of Process Analytical Technology (PAT) Towards Bioprocessing”, IFPAC Annual Meeting, Baltimore, MD, January, 2009
138. A. S. Rathore, "Implementation of QbD for Biopharmaceuticals: Approach and Case Studies”, 2008 PDA/FDA Join Regulatory Conference, Washington DC, September, 2008
139. A. S. Rathore et al, “Implementation of QbD for Biopharmaceuticals: Approach, Case Studies and Integration with PAT”, 236th ACS National Meeting, Philadelphia, PA, August, 2008
140. A. S. Rathore and Gail Sofer “Process Validation for Biopharmaceuticals”, PDA Training and Research Institute Course Series, San Francisco, March, 2008
141. A. S. Rathore, "Quality by Design: Case Studies”, 2007 PDA/FDA Join Regulatory Conference, Washington DC, September, 2007
142. A. S. Rathore et al, “Application of Multivariate Analysis towards Biotech Processes: Case Study of a Cell-Culture Unit Operation”, 234th ACS National Meeting, Boston, MA, August, 2007
143. A. S. Rathore,  “QbD from Past to Present”, PDA Workshop on QbD for Biopharmaceuticals, Bethesda, MD, May, 2007
144. A. S. Rathore,  “Biotech Processing: Challenges and Approach”, Biotech Symposium, University of California at Los Angeles (UCLA), Los Angeles, CA, June, 2007 
145. A. S. Rathore, “PAT Application for Biotech Products: Use of Multivariate Analysis”, PDA 2007 Annual Meeting, Las Vegas, NV, March, 2007
146. A. S. Rathore and Gail Sofer “Process Validation for Biopharmaceuticals”, PDA Training and Research Institute Course Series, Las Vegas, NV, March, 2007
147. A. S. Rathore, “Linking Process Characterization to Process Validation”, InvitedLecture, IBC’s 11th International Conference on Process Validation, Carlsbad, CA, March, 2007
148. A. S. Rathore, "Scale-down Modeling and Determination of Media Lifetime", InvitedLecture, Course on Bioprocess Purification Process Development, ASME, Montreal, CA, October, 2006
149. A. S. Rathore et al," Technology Transfer of Biotech Processes: Issues and Solutions", Lecture, 232nd ACS National Meeting, San Francisco, CA, September, 2006.
150. A. S. Rathore, "Interplay of Chromatographic and Electrophoretic Processes in CEC", Lecture, HPLC 2006, San Francisco, CA, June, 2006.
151. A. S. Rathore et al, "Challenges in Applying PAT towards Biotech Processing", Lecture, CaSSS’ Application of Process Analytical Technology in the Biotechnology Industry, San Francisco, CA, June, 2006.
152. A. S. Rathore, "Process Characterization, Validation and Monitoring", InvitedLecture, 2006 PDA Workshop on Biotech Process Validation, Anaheim, CA, April, 2006.
153. A. S. Rathore et al, "Process Analytical Technology (PAT) Applications for Downstream Unit Operations", InvitedLecture, 2006 PDA Annual Meeting, Anaheim, CA, April, 2006.
154. A. S. Rathore, "Scale-down Modeling and Determination of Media Lifetime", InvitedLecture, Course on Bioprocess Purification Process Development, ASME, Seattle, WA, September, 2005.
155. A. S. Rathore et al, "Comparison of Different Harvest Approaches for Harvest of a Therapeutic Protein Product from High Cell Density Yeast Fermentation Broth", InvitedLecture, IBC’s 2nd Annual BioProcess International Conference, Boston, MA, September, 2005.
156. A. S. Rathore et al," Process Analytical Technology Applications with Biotechnology Unit Operations", InvitedLecture, IBC’s Conference on Process Analytical Technology, Vienna, VA, June, 2005.
157. A. S. Rathore," Validation of Chromatography and Membrane Media Lifetime", InvitedLecture, IBC’s Conference on Process Validation, San Diego, CA, March, 2005.
158. A. S. Rathore et al," Use of Immobilized Use of Immobilized Metal Affinity Chromatography as a Capture Mode for Purification of a Microbial Product ", InvitedLecture, 229th ACS National Meeting, San Diego, CA, March, 2005.
159. A. S. Rathore et al," Use of Electrokinetic Measurements for Characterization of Columns used in Capillary Electrochromatography ", InvitedLecture, 229th ACS National Meeting, San Diego, CA, March, 2005.
160. A. S. Rathore et al," Interplay of Chromatographic and Electrophoretic Processes in Capillary Electrochromatography ", InvitedLecture, Pittcon 2005, Orlando, FL, February, 2005.
161. A. S. Rathore et al," Case Study on Scale-up and Scale down in Biopharmaceutical Production", InvitedLecture, IBC/ Bioprocess International Conference, Boston, MA, October, 2004.
162. A. S. Rathore," Production Scenario I:  Scale-up of a Typical Recombinant Protein Process", InvitedLecture, Course on Bioprocess Purification Process Development, ASME, Atlanta, GA, October, 2004.
163. A. S. Rathore et al," Scale-down Modeling and Characterization of a Protein Refolding Step", Lecture, 227th ACS National Meeting, Anaheim, March 28-April 1, 2004.
164. A. S. Rathore et al," Use of Scale-down Models in Support of Process Validation", InvitedLecture, IBC’s Conference on Process Validation, San Diego, CA, February, 2004.
165. A. S. Rathore," Production Scenario II:  Scale-up of a Typical Recombinant Protein Process", InvitedLecture, Course on Bioprocess Purification Process Development, ASME, New Orleans, LA, October, 2003.
166. A. S. Rathore, "Optimization of an Osmotic Shock Procedure for Isolation of a Protein Product Expressed in E. coli", Lecture, ACS 2003, New Orleans, LA, March, 2003.
167. A. S. Rathore," Explore an Approach to Process Validation for an Acceptable Validation Package", InvitedLecture, Course on Process Validation, Barnett International, Philadelphia, PA, January 2003.
168. A. S. Rathore," Joule Heating in Capillary Electrochromatography", Lecture, ACS 2002, Boston, MA, August 2002.
169. A. S. Rathore," Enhancement of Electroosmotic Flow in Capillary Electrochromatography", Lecture, HPLC 2002, Montreal, Canada, June 2002.
170. A. S. Rathore," Development and Large Scale Demonstration of Enhanced Purification Process for Pegvisomant/ SomavertTM Bulk Intermediate", Lecture, TECH 2002, St. Louis, MO, May, 2002.
171. A. S. Rathore," Challenges in Purification of Biotechnology Products", InvitedLecture, Washington University at St. Louis, St. Louis, MO, October, 2001.
172. A. S. Rathore," Process Characterization of Chromatography Steps ", Lecture, TECH 2001, St. Louis, MO, May, 2001.
173. A. S. Rathore, "Introduction to Liquid Chromatography", Lecture, Pharmacia Pilot Plant, St. Louis, MO, October, 2000.
174. A. S. Rathore, " Resin screening for optimization of chromatographic separations", Lecture, TCM Tech 2000, May, 2000.
175. A. S. Rathore, "Resin screening for optimization of chromatographic separations", Lecture, 219th ACS National Meeting, San Francisco, CA, March, 2000.
176. A. S. Rathore et al, "Axial nonuniformities of electric field and electrosmotic flow in columns used in capillary electrochromatography", Lecture, 9th Frederick Conference on Capillary Electrophoresis, Frederick, MD, October, 1998.
177. A. S. Rathore et al, "Flow of ions and bulk fluid in CEC", Invited Lecture, Northeastern University, Boston, MA, October, 1998.
178. A. S. Rathore , "Distribution of electrosmotic flow in capillary electrochromatographic columns", Invited Lecture, Sandia National Laboratory, Livermore, CA, May, 1998.
179. A. S. Rathore et al, "Axial nonuniformities and flow in columns for capillary electrochromatography", Lecture, HPLC'98, St. Louis, MO, May, 1998.
180. A. S. Rathore , "Studies on separation of peptides and proteins by CE and LC", Invited Lecture, Indian Institute of Sciences (IISc), Bangalore, India, November, 1997.
181. A. S. Rathore et al, "Migration parameters in HPLC, CZE and CEC", Lecture, CEC Workshop, HPCE'97, Anaheim, CA, January, 1997.
182. A. S. Rathore et al, "Enhancement of electrosmotic flow at high electric field in CEC", Lecture, HPCE'97, Anaheim, CA, January, 1997.
183. A. S. Rathore et al, "Displacement chromatography with on-column isomerization of feed components", Lecture, ACS Annual Spring Meeting, New Orleans, March, 1996.